Target intelligence / Profile preview

Guanine nucleotide-binding protein G(s) subunit alpha (GNAS)

Target
GNAS
Molecular classification
G protein, G protein-coupled receptor-associated protein, GTPase, Signaling protein
01

Overview

Guanine nucleotide-binding protein G(s) subunit alpha (Gs alpha), encoded by the GNAS complex locus, is a critical heterotrimeric G-protein subunit that acts as a molecular switch in signal transduction pathways. Upon activation by ligand-bound G protein-coupled receptors (GPCRs), Gs alpha exchanges GDP for GTP, dissociates from the G beta-gamma dimer, and directly stimulates adenylyl cyclase, leading to an increase in intracellular cyclic AMP (cAMP) and subsequent activation of protein kinase A (PKA). This pathway regulates numerous physiological processes, including endocrine hormone signaling, metabolism, and cell proliferation.

Activating somatic mutations in GNAS (often referred to as the gsp oncogene) lead to constitutive cAMP signaling and are associated with McCune-Albright syndrome, fibrous dysplasia, and various tumors, such as pituitary adenomas and appendiceal mucinous neoplasms. Conversely, inactivating mutations cause Albright's hereditary osteodystrophy and pseudohypoparathyroidism. While Gs alpha has historically been considered difficult to drug directly, research tools and investigational agents like the selective antagonist NF449 and bacterial toxins like cholera toxin (which ADP-ribosylates Gs alpha to keep it active) are used to modulate its function. Additionally, downstream or parallel pathways in GNAS-mutant cancers are being targeted clinically with drugs like the CDK4/6 inhibitor palbociclib.

Other names
Gs alpha subunitGαsG stimulatory protein alpha subunitAdenylate cyclase-stimulating G alpha proteinGNAS complex locusGsp oncogene
02

Mechanism of action

Direct inhibition of Gs alpha subunit activation, ADP-ribosylation of Gs alpha subunit leading to constitutive activation, and inhibition of GDP-to-GTP exchange

03

Biological functions

Signal transductioncAMP biosynthesisAdenylyl cyclase activationGTPase activityHormone signaling
04

Disease associations

CancerEndocrine diseaseMcCune-Albright syndromeAlbright's hereditary osteodystrophyPseudohypoparathyroidismFibrous dysplasia
05

Safety considerations

Pleiotropic side effects due to widespread expressionAlterations in hormone sensitivityCardiovascular effectsEndocrine dysfunction
06

Interacting drugs

NF449

2 more in the full profile.

07

Biomarkers

GNAS mutation statuscAMP levelsCarcinoembryonic antigen (CEA)

Beyond the preview

Go deeper on Guanine nucleotide-binding protein G(s) subunit alpha (GNAS).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Guanine nucleotide-binding protein G(s) subunit alpha (GNAS).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call